Taegon Baik,Seyeon Kim,Ju-Hee Kim,Seung Han Song,Young-Joon Park,Kyung Mi Park
申请号：
US16336971
公开号：
US20190224195A1
申请日:
2017.09.27
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention relates to a capsule composite formulation comprising dutasteride represented by formula I, tadalafil represented by formula II, a fatty acid ester derivative having 8 to 10 carbon atoms, and a polysorbate- or polyoxylglyceride-based surfactant wherein both the two drugs are dissolved.
